When and which COVID-19 vaccines are likely to be available in Asia

The head of the Serum Institute of India, which makes the AstraZeneca vaccine, said on Nov 23 the positive late-state trial result of the candidate will allow it to seek emergency use authorisation by year-end, before gaining approval for a full rollout by February or March next year.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/365qqcP
via IFTTT